TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group
Giulia Tueur
(1)
,
Virginie Eclache
(1)
,
Grégory Lazarian
(1)
,
Carole Fleury
(1)
,
Rémi Letestu
(1)
,
Vincent Lévy
(1)
,
Jean-François Collon
(1)
,
Jean-Marc Zini
(2)
,
Catherine Thieblemont
(2)
,
Florence Cymbalista
(1)
,
Fanny Baran-Marszak
(3, 1)